Derek Adams
Director/Board Member at ALLOVIR, INC.
Net worth: 52 850 $ as of 2024-05-30
Derek Adams active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALLOVIR, INC. | Director/Board Member | 2023-02-28 | - |
| Independent Dir/Board Member | 2023-02-28 | - |
Career history of Derek Adams
Former positions of Derek Adams
| Companies | Position | Start | End |
|---|---|---|---|
Stellular Bio, Inc.
 Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Chief Executive Officer | 2022-02-28 | 2022-10-31 |
| Chief Operating Officer | 2021-07-07 | - | |
| President | 2022-02-28 | 2022-10-31 | |
| BLUEBIRD BIO, INC. | Chief Tech/Sci/R&D Officer | 2017-03-19 | 2021-06-30 |
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | 2016-01-31 | 2016-05-31 |
| ALEXION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2015-05-31 | 2016-01-31 |
Training of Derek Adams
| University of Minnesota | Doctorate Degree |
| Worcester Polytechnic Institute | Undergraduate Degree |
Statistics
International
| United States | 8 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| ALLOVIR, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Stellular Bio, Inc.
Stellular Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Stellular Bio, Inc. develops technology to produce independent human platelets from human induced pluripotent stem cells. The company was founded by Jonathan Thon, Joseph Italiano and Sven Karlsson in 2014 and is headquartered in Watertown, MA. | Commercial Services |
- Stock Market
- Insiders
- Derek Adams
- Experience
